Neuropsychiatry Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Neuropsychiatry

Neuropsychiatry is an integral part of medicine and science which deals with mental disorders related to the nervous system. Neuropsychiatry is to study neurology and psychiatry in an integrated form. Neuropsychiatry is growing far from other fields of psychiatry and it is also interconnected with behavioral neurology and neuropsychology.

Neuropsychiatry helps the neuroscience field and is helping to give a better understanding of the psychiatry and neurological disorders in order to treat them in a far better way.

Neuropsychiatrists are the physician who has clinical experience and experience in psychiatry with knowledge of neurological disorders. Neuropsychiatrists primarily treat patients suffering from brain malfunctions. Neuropsychiatrists treats these condition with the help of some tools: functional magnetic resonance tomography (fMRI), clinical neurogenetics, magnetic resonance angiography, neuroimaging, electroencephalography, and neural network theory.

Neuropsychiatry addresses these various conditions under it: patients of Parkinson's with delusion and hallucinations, obsessive-compulsive disorder, schizophrenia, and other conditions as well.

Sub-tracks:

Psychiatric genetics
Psycho-oncology
Mind/brain monism
Psychiatric epidemiology
Cultural and religious considerations
Mental well-being and mental illness

Market Analysis: The Neuropsychiatry market is poised for significant expansion from 2025 to 2030, driven by the increasing burden of brain disorders, continuous advancements in neurotechnology and diagnostics, rising R&D spending, and growing government support. While the overall market CAGRs generally range from 3.9% to 10.34%, key sub-segments like Neurotechnology (12.2% to 14.4% CAGR) and Digital Neuro Biomarkers (25.7% CAGR, including Psychiatric Digital Biomarkers at 24.4% CAGR) show much higher growth. This highlights a dynamic neuropsychiatry sector developing innovative solutions for neurological and psychiatric conditions, with a notable shift towards personalized and remote care.

Tracks